March 31, 2021 March 31, 2021Categories Active Clinical TrialsNow Enrolling: EA6194 for Operable MelanomaThis phase II study, led by Dr. Ahmad Tarhini, is testing neoadjuvant treatment with pembrolizumab alone versus pembrolizumab and an investigational drug called CMP-001
January 14, 2020 January 14, 2020Categories Institution SpotlightsInstitution Spotlight: Fox Chase Cancer CenterA Standing Main Member of ECOG-ACRIN since 1971
![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
